Non-Invasive Brain Stimulation and Migraines
common.study.values.description
“Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo)”
This study investigates whether non-invasive brain stimulation, given for 20 minutes/once per day for ten days (M-F) can reduce migraine pain. Thirty patients will receive this treatment, while thirty will receive a "sham" procedure. Up to thirty healthy volunteers will be asked to undergo baseline assessments only (imaging, but no brain stimulation). Healthy volunteer data may be used from a prior study (NINDS-K23062946 project [IRBMED #HUM00027383; Dr. Alexandre DaSilva, Principal Investigator]).
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
Device - Active Comparator
non-invasive brain stimulation (active protocol)
Device - Sham Comparator
non-invasive brain stimulation (sham protocol)
participant.views.study.view.additional
participant.views.study.view.scientific-title
Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo)
common.study.values.clinical-trial-id
NCT02964741
participant.views.study.view.id
DdwA1a
